Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

Leach pad failure at Çöpler has drastically altered SSR Mining's financial profile, but it won't be a fatal blow. Read why SSRGF stock is a Hold.

Patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and high body mass index ...

In a meta-analysis, second-generation BTK inhibitors were linked to a significantly low incidence of atrial fibrillation, ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...

The rates of heart failure were 4.83% and 2.54%, respectively. Additionally, 1.23% of patients in the first-generation group ...

Just 1.5 to 4 minute small bursts of high intensity exercise throughout the day may lower a person’s risk of major cardiovascular events, such as stroke.

Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.